Daniel Neureiter Selected Research

Daniel Neureiter Research Topics

Disease

60	Neoplasms (Cancer) 07/2021 - 04/2002
16	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 10/2003
16	Biliary Tract Neoplasms (Biliary Tract Cancer) 02/2022 - 05/2010
11	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2002
9	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 01/2005
8	Inflammation (Inflammations) 12/2021 - 05/2003
7	Carcinogenesis 04/2022 - 04/2010
6	Carcinoma (Carcinomatosis) 02/2020 - 12/2007
6	Liver Neoplasms (Liver Cancer) 06/2019 - 01/2009
5	Infections 09/2022 - 05/2003
4	Adenocarcinoma 01/2020 - 01/2009
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2007
3	Anemia 05/2021 - 12/2015
3	Rectal Neoplasms (Rectal Cancer) 08/2020 - 08/2017
3	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 11/2015
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018 - 01/2017
3	Fibrosis (Cirrhosis) 03/2017 - 12/2009
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2016 - 12/2015
3	Atherosclerotic Plaque (Atheroma) 05/2015 - 01/2008
3	Atherosclerosis 05/2015 - 05/2005
3	Phototoxic Dermatitis (Phototoxicity) 11/2014 - 05/2010
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2014 - 01/2011
3	Cholestasis 06/2013 - 01/2009
2	Body Weight (Weight, Body) 12/2021 - 02/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2011
2	Hematologic Neoplasms (Hematological Malignancy) 05/2021 - 01/2016
2	Chronic Disease (Chronic Diseases) 09/2018 - 05/2015
2	Hemorrhage 05/2018 - 02/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 10/2015
2	Chronic Hepatitis C 03/2017 - 03/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2017 - 02/2012
2	Disease Progression 11/2016 - 04/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2016 - 02/2015
2	Necrosis 01/2016 - 01/2004
2	Bile Duct Neoplasms (Bile Duct Cancer) 11/2015 - 06/2013
2	Neuroblastoma 01/2015 - 04/2010
2	Glioma (Gliomas) 09/2014 - 01/2013
2	Sepsis (Septicemia) 09/2014 - 06/2004
2	Pheochromocytoma 01/2011 - 04/2010
2	Paraganglioma (Paragangliomas) 01/2011 - 04/2010
2	Cholangiocarcinoma 05/2010 - 01/2009
2	Stroke (Strokes) 05/2005 - 05/2003

Drug/Important Bio-Agent (IBA)

9	Histone Deacetylases (Histone Deacetylase)IBA 07/2021 - 01/2007
9	Biomarkers (Surrogate Marker)IBA 02/2020 - 04/2002
9	PanobinostatIBA 08/2018 - 01/2010
8	Proteins (Proteins, Gene)FDA Link 07/2021 - 08/2012
8	MicroRNAs (MicroRNA)IBA 10/2019 - 06/2014
8	Histone Deacetylase InhibitorsIBA 06/2019 - 06/2005
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2015 - 01/2009
5	Pharmaceutical PreparationsIBA 04/2022 - 06/2012
5	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2007
5	Histones (Histone)IBA 05/2015 - 09/2012
5	EnzymesIBA 01/2015 - 04/2010
4	CytokinesIBA 01/2021 - 08/2009
4	Fluorouracil (Carac)FDA LinkGeneric 08/2020 - 06/2005
4	Biological ProductsIBA 04/2020 - 04/2002
4	Rituximab (Mabthera)FDA Link 11/2016 - 08/2011
4	Gemcitabine FDA Link 08/2015 - 03/2007
4	VimentinIBA 01/2013 - 01/2005
4	Small Interfering RNA (siRNA)IBA 09/2012 - 03/2007
3	Peptides (Polypeptides)IBA 12/2021 - 03/2017
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2013
3	Integrin alpha4beta1 (VLA-4)IBA 01/2021 - 01/2011
3	Cetuximab (Erbitux)FDA Link 01/2019 - 10/2015
3	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 11/2015 - 05/2010
3	temoporfinIBA 11/2015 - 05/2010
3	Heme Oxygenase-1IBA 07/2014 - 09/2008
3	MethyltransferasesIBA 06/2014 - 01/2007
2	C-Reactive ProteinIBA 05/2020 - 12/2015
2	Tumor Biomarkers (Tumor Markers)IBA 02/2020 - 04/2002
2	Carcinoembryonic AntigenIBA 02/2020 - 11/2011
2	InterferonsIBA 03/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 01/2016
2	OligonucleotidesIBA 01/2016 - 09/2012
2	AntibodiesIBA 12/2015 - 05/2003
2	Cisplatin (Platino)FDA LinkGeneric 10/2015 - 06/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2015 - 01/2011
2	Azacitidine (5 Azacytidine)FDA Link 04/2014 - 08/2011
2	CD40 Ligand (CD40L)IBA 01/2013 - 01/2007
2	Keratins (Keratin)IBA 01/2013 - 08/2012
2	Phosphotransferases (Kinase)IBA 08/2011 - 01/2009
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2011 - 04/2010
2	Differentiation AntigensIBA 01/2010 - 01/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2009 - 10/2008
2	Epidermal Growth Factor (EGF)IBA 01/2009 - 10/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	IronIBA 04/2022

Therapy/Procedure

30	Therapeutics 02/2022 - 03/2007
8	Drug Therapy (Chemotherapy) 01/2022 - 03/2007
6	Photochemotherapy (Photodynamic Therapy) 11/2015 - 01/2009
5	Radiofrequency Ablation 03/2018 - 10/2003
4	Immunotherapy 06/2021 - 01/2017
4	Chemoradiotherapy 08/2017 - 12/2010
4	Palliative Care (Palliative Therapy) 05/2016 - 01/2009
3	Neoadjuvant Therapy 08/2020 - 01/2009
2	Ketogenic Diet 01/2019 - 01/2015
2	Colectomy 05/2018 - 01/2011
2	Ligation 05/2015 - 12/2009